Production (Stage)
Scinai Immunotherapeutics Ltd.
SCNI
$2.69
-$0.0407-1.49%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.23M | -2.32M | -2.33M | 3.11M | -3.52M |
| Total Depreciation and Amortization | 499.00K | 496.00K | 84.00K | 145.00K | 138.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 180.00K | 371.00K | -2.92M | -1.12M | 2.61M |
| Change in Net Operating Assets | 475.00K | -303.00K | 3.94M | -4.35M | -2.29M |
| Cash from Operations | -1.08M | -1.76M | -1.23M | -2.22M | -3.06M |
| Capital Expenditure | 0.00 | -6.00K | -234.00K | -20.00K | -6.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 0.00 | -6.00K | -234.00K | -20.00K | -6.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 1.43M | 0.00 | 1.09M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.00M | -1.42M | -- | -- | -- |
| Cash from Financing | 2.00M | 12.00K | 0.00 | 1.09M | -- |
| Foreign Exchange rate Adjustments | 2.00K | -121.00K | -14.00K | 7.00K | -224.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 926.00K | -1.87M | -1.47M | -1.15M | -3.29M |